References

Momtazmanesh S, Saeedi Moghaddam S, Malakan Rad E, et al. Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019. European Journal of Preventive Cardiology. 2022;29(8):1287-1297.

Jensen AD, Ostergaard L, Petersen JK, et al. Temporal trends of mortality in patients with infective endocarditis: a nationwide study. European Heart Journal - Quality of Care and Clinical Outcomes. 2022;9(1):24-33.

Shah ASV, McAllister DA, Gallacher P, et al. Incidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis. Circulation. 2020;141(25):2067-2077.

Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Internal Medicine. 2013;173(16):1495-1504.

Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine. 2009;169(5):463-473.

Selton-Suty C, Celard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clinical Infectious Diseases. 2012;54(9):1230-1239.

Chu VH, Park LP, Athan E, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131(2):131-140.

Graversen PL, Ostergaard L, Hadji-Turdeghal K, et al. Clinical Practice of Surgical Treatment for Left-Sided Infective Endocarditis: Nationwide Data from the NIDUS Registry. Circulation. 2025;152(17):1221-1233.

Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. European Heart Journal. 2019;40(39):3222-3232.

Jensen AD, Ostergaard L, Petersen JK, et al. Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide study. BMC Cardiovascular Disorders. 2022;22(1):338.

Olmos C, Vilacosta I, Fernandez-Perez C, et al. The Evolving Nature of Infective Endocarditis in Spain: A Population-Based Study (2003 to 2014). Journal of the American College of Cardiology. 2017;70(22):2795-2804.

Thornhill MH, Jones S, Prendergast B, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. European Heart Journal. 2018;39(7):586-595.

Thornhill MH, Gibson TB, Yoon F, et al. Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures. Journal of the American College of Cardiology. 2022;80(11):1029-1041.

Thornhill MH, Gibson TB, Yoon F, et al. Endocarditis, invasive dental procedures, and antibiotic prophylaxis efficacy in US Medicaid patients. Oral Diseases. 2024;30(3):1591-1605.

Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. Journal of the American Medical Association. 2005;293(24):3022-3028.

Mylonakis E, Calderwood SB. Infective endocarditis in adults. The New England Journal of Medicine. 2001;345(18):1318-1330.

DeSimone DC, Tleyjeh IM, Correa de Sa DD, et al. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. American Heart Journal. 2015;170(4):830-836.

Ostergaard L, Voldstedlund M, Bruun NE, et al. Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study. Journal of the American Heart Association. 2022;11(16):e025801.

Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. European Heart Journal. 2023;44(39):3948-4042.

Lockhart PB, Brennan MT, Thornhill M, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. Journal of the American Dental Association. 2009;140(10):1238-1244.

NICE Guideline 64. Prophylaxis against infective endocarditis: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. 2008. Updated 2015. Amended 2016.
www.nice.org.uk/Guidance/CG64. Accessed 2 February 2026.

2024 exceptional surveillance of prophylaxis against infective endocarditis (NICE guideline CG64). 2024;
www.nice.org.uk/guidance/cg64/resources/2024-exceptional-surveillance-of-prophylaxis-against-infective-endocarditis-nice-guideline-cg64-13549556845/chapter/Surveillance-proposal?tab=evidence. Accessed 2 February 2026.

Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021;143(20):e963-e978.

Montgomery v Lanarkshire Health Board UKSC/2013/0136. 2015;
www.supremecourt.uk/cases/uksc-2013-0136. Accessed 2 February 2026.

Adults with Incapacity (Scotland) Act 2000.  
https://www.legislation.gov.uk/asp/2000/4/contents. Accessed 29 January 2026.

Mental Capacity Act 2005.  
https://www.legislation.gov.uk/ukpga/2005/9/contents. Accessed 26 January 2026

Mental Capacity Act (Northern Ireland) 2016.  
https://www.legislation.gov.uk/nia/2016/18/contents/enacted. Accessed 26 January 2026.

McCulloch and others v Forth Valley Health Board UKSC/2021/0149. 2023;
www.supremecourt.uk/cases/uksc-2021-0149. Accessed 2 February 2026.

Standards for the Dental Team. General Dental Council. 2013;
https://www.gdc-uk.org/standards-guidance/standards-and-guidance/standards-for-the-dental-team. Accessed 2 February 2026.

NICE Guideline 197. Shared decision making. 2021;
www.nice.org.uk/guidance/ng197. Accessed 2 February 2026.

Thornhill M, Prendergast B, Dayer M, Frisby A, Lockhart P, Baddour LM. Prevention of infective endocarditis in at-risk patients: how should dentists proceed in 2024? British Dental Journal. 2024;236(9):709-716.

Prevention and Treatment of Periodontal Diseases in Primary Care 2nd Edition. Scottish Dental
Clinical Effectiveness Programme. 2024;
www.periodontalcare.sdcep.org.uk/. Accessed 2 February 2026.

Kussainova Z, Kulmaganbetov M, Abiltayev A, Bulegenov T, Salikhanov I. Risk of Infective
Endocarditis Following Invasive Dental Procedures: A Systematic Review and Meta-Analysis.
Public Health Reviews. 2024;45:1607684.

Gillick v West Norfolk & Wisbech AHA & DHSS [1985] 3 WLR (HL).
www.bailii.org/uk/cases/UKHL/1985/7.html. Accessed 2 February 2026.

Age of Legal Capacity (Scotland) Act 1991.  
www.legislation.gov.uk/ukpga/1991/50/contents. Accessed 2 February 2026.

Prevention and Management of Dental Caries in Children 3rd Edition. Scottish Dental Clinical Effectiveness Programme. 2025;
www.childcaries.sdcep.org.uk/. Accessed 2 February 2026.

In the Spotlight - article 15: The Importance of Documenting ‘Antibiotic Items Prescribed’ (Wales only). 2025;
https://www.nhsbsa.nhs.uk/compass/resources-dental-practices. Accessed 2 February 2026.

English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) Report 2024 to 2025.
2025; https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report. Accessed 2 February 2026.

Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2024 Report. 2025;
https://www.nss.nhs.scot/publications/scottish-one-health-antimicrobial-use-and-antimicrobial-resistance-in-2024/. Accessed 2 February 2026.

Surveillance of Antimicrobial Use and Resistance in Northern Ireland, Annual Reports. 2024;
https://www.publichealth.hscni.net/publications/surveillance-antimicrobial-use-and-resistance-northern-ireland-annual-reports. Accessed 2 February 2026.

Khalil D, Hultin M, Rashid MU, Lund B. Oral microflora and selection of resistance after a single dose of amoxicillin. Clinical Microbiology and Infection. 2016;22(11):949 e941-949 e944.

Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. The Journal of Antimicrobial Chemotherapy. 2007;60(5):1172-1173.

Thornhill MH, Dayer MJ, Prendergast B, Baddour LM, Jones S, Lockhart PB. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. The Journal of Antimicrobial Chemotherapy. 2015;70(8):2382-2388.

British National Formulary. Ed 90. London: BMJ Group and Pharmaceutical Press; 2025.

Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. The Journal of Antimicrobial Chemotherapy. 2006;57(6):1035-1042.